Susan Fox
Susan Fox
Associate Professor University of Toronto
Verified email at uhnresearch.ca
TitleCited byYear
Movement Disorder Society‐sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS): scale presentation and clinimetric testing results
CG Goetz, BC Tilley, SR Shaftman, GT Stebbins, S Fahn, ...
Movement disorders: official journal of the Movement Disorder Society 23 (15 …, 2008
24602008
The Movement Disorder Society Evidence‐Based Medicine Review Update: Treatments for the non‐motor symptoms of Parkinson's disease
K Seppi, D Weintraub, M Coelho, S Perez‐Lloret, SH Fox, ...
Movement Disorders 26 (S3), S42-S80, 2011
7812011
The Movement Disorder Society Evidence‐Based Medicine Review Update: Treatments for the motor symptoms of Parkinson's disease
SH Fox, R Katzenschlager, SY Lim, B Ravina, K Seppi, M Coelho, ...
Movement Disorders 26 (S3), S2-S41, 2011
5442011
Prevalence of repetitive and reward-seeking behaviors in Parkinson disease
V Voon, K Hassan, M Zurowski, M De Souza, T Thomsen, S Fox, AE Lang, ...
Neurology 67 (7), 1254-1257, 2006
4362006
A comparison of the mini mental state exam to the Montreal cognitive assessment in identifying cognitive deficits in Parkinson's disease
C Zadikoff, SH Fox, DF Tang‐Wai, T Thomsen, RMA De Bie, P Wadia, ...
Movement disorders 23 (2), 297-299, 2008
3832008
Medication-related impulse control and repetitive behaviors in Parkinson disease
V Voon, SH Fox
Archives of Neurology 64 (8), 1089-1096, 2007
3742007
Prospective prevalence of pathologic gambling and medication association in Parkinson disease
V Voon, K Hassan, M Zurowski, S Duff-Canning, M De Souza, S Fox, ...
Neurology 66 (11), 1750-1752, 2006
3522006
Factors associated with dopaminergic drug–related pathological gambling in Parkinson disease
V Voon, T Thomsen, JM Miyasaki, M de Souza, A Shafro, SH Fox, ...
Archives of Neurology 64 (2), 212-216, 2007
3432007
Cannabinoids reduce levodopa-induced dyskinesia in Parkinson’s disease: a pilot study
KA Sieradzan, SH Fox, M Hill, JPR Dick, AR Crossman, JM Brotchie
Neurology 57 (11), 2108-2111, 2001
2982001
Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease
MF Bastide, WG Meissner, B Picconi, S Fasano, PO Fernagut, M Feyder, ...
Progress in neurobiology 132, 96-168, 2015
2312015
The pharmacology of L-DOPA-induced dyskinesia in Parkinson’s disease
P Huot, TH Johnston, JB Koprich, SH Fox, JM Brotchie
Pharmacological reviews 65 (1), 171-222, 2013
2132013
Serotonin 2A receptors and visual hallucinations in Parkinson disease
B Ballanger, AP Strafella, T van Eimeren, M Zurowski, PM Rusjan, ...
Archives of neurology 67 (4), 416-421, 2010
1902010
Overview of the extranigral aspects of Parkinson disease
SY Lim, SH Fox, AE Lang
Archives of neurology 66 (2), 167-172, 2009
1802009
A role for endocannabinoids in the generation of parkinsonism and levodopa-induced dyskinesia in MPTP-lesioned non-human primate models of Parkinson’s disease
M van der Stelt, SH Fox, M Hill, AR Crossman, S Petrosino, V Di Marzo, ...
The FASEB journal 19 (9), 1140-1142, 2005
1762005
Stimulation of cannabinoid receptors reduces levodopa‐induced dyskinesia in the MPTP‐lesioned nonhuman primate model of Parkinson's disease
SH Fox, B Henry, M Hill, A Crossman, J Brotchie
Movement disorders: official journal of the Movement Disorder Society 17 (6 …, 2002
1632002
Fipamezole (JP‐1730) is a potent α2 adrenergic receptor antagonist that reduces levodopa‐induced dyskinesia in the MPTP‐lesioned primate model of Parkinson …
JM Savola, M Hill, M Engstrom, H Merivuori, S Wurster, SG McGuire, ...
Movement disorders: official journal of the Movement Disorder Society 18 (8 …, 2003
1612003
Increased striatal pre-proenkephalin B expression is associated with dyskinesia in Parkinson’s disease
B Henry, S Duty, SH Fox, AR Crossman, JM Brotchie
Experimental neurology 183 (2), 458-468, 2003
1602003
Clinical spectrum of levodopa‐induced complications
CC Aquino, SH Fox
Movement Disorders 30 (1), 80-89, 2015
1542015
The serotonergic system in Parkinson's disease
P Huot, SH Fox, JM Brotchie
Progress in neurobiology 95 (2), 163-212, 2011
1522011
Serotonin and Parkinson's disease: On movement, mood, and madness
SH Fox, R Chuang, JM Brotchie
Movement disorders: official journal of the Movement Disorder Society 24 (9 …, 2009
1522009
The system can't perform the operation now. Try again later.
Articles 1–20